By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Nevro Corp 

4040 Campbell Avenue
Suite 210
Menlo Park  California  94025  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
Menlo Park's Nevro Corp Sets Terms For $100 Million IPO 10/29/2014 7:06:45 AM
Back Pain Stimulates $125 Million IPO For Menlo Park's Nevro Corp 10/5/2014 9:10:28 AM
Nevro Corp Strengthens Leadership Team With The Appointment Of David Caraway, MD, PhD As Chief Medical Officer 3/31/2014 6:24:49 AM
Nevro Corp Announces Publication Of 24-Month European Clinical Data On HF10 Spinal Cord Stimulation (SCS) Therapy For Chronic Back And Leg Pain 3/12/2014 10:21:12 AM
Nevro Corp Completes Enrollment of U.S. Randomized Pivotal Trial of Novel Chronic Pain Treatment 3/12/2013 9:48:58 AM
Nevro Corp Closes $48 Million in New Financing 3/7/2013 7:15:09 AM
Nevro Corp Announces Publication of Positive Six-Month Clinical Data for Senza® HF10™ High-Frequency Spinal Cord Stimulation Therapy in Europe 2/6/2013 9:16:14 AM
Nevro Corp Announces Issuance of Additional Key U.S. Patents for Innovative Chronic Pain Treatment 1/24/2013 9:50:36 AM
Nevro Corp Announces Issuance of Key U.S. Patents for Innovative Chronic Pain Treatment 6/27/2012 9:52:51 AM
Nevro Corp Receives FDA Approval to Initiate Landmark US Chronic Pain Treatment Trial 5/23/2012 7:34:17 AM
//-->